MEKK3 regulates IFN-γ production in T cells through the Rac1/2-dependent MAPK cascades

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 5791-5800

  Wang, Xiaofang ^a,b   Zhang, Fan ^a,c   Chen, Fanping ^c   Liu, Dou ^a   Zheng, Yi ^d   Zhang, Yongliang ^e   Dong, Chen ^e   Su, Bing ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RAC1 PROTEIN; RAC2 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LISTERIOSIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADAPTIVE IMMUNITY; AMINOQUINOLINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; FLOW CYTOMETRY; IMMUNOBLOTTING; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; LISTERIA MONOCYTOGENES; MAP KINASE KINASE KINASE 3; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; PYRIMIDINES; RAC GTP-BINDING PROTEINS; RAC1 GTP-BINDING PROTEIN; RECEPTORS, ANTIGEN, T-CELL;

EID: 79956207794     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002127     Document Type: Article

References (45)

1. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410: 37-40. (Pubitemid 32225829)
2. Raman, M., W. Chen, and M. H. Cobb. 2007. Differential regulation and properties of MAPKs. Oncogene 26: 3100-3112.
3. Avruch, J. 2007. MAP kinase pathways: the first twenty years. Biochim. Biophys. Acta 1773: 1150-1160.
4. Su, B., and M. Karin. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8: 402-411.
5. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20: 55-72.
6. Rincón, M., and R. J. Davis. 2009. Regulation of the immune response by stress-activated protein kinases. Immunol. Rev. 228: 212-224.
7. Huang, G., L. Z. Shi, and H. Chi. 2009. Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination. Cytokine 48: 161-169.
8. Blank, J. L., P. Gerwins, E. M. Elliott, S. Sather, and G. L. Johnson. 1996. Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. J. Biol. Chem. 271: 5361-5368.
9. Ellinger-Ziegelbauer, H., K. Brown, K. Kelly, and U. Siebenlist. 1997. Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative. J. Biol. Chem. 272: 2668-2674.
10. Yang, J., M. Boerm, M. McCarty, C. Bucana, I. J. Fidler, Y. Zhuang, and B. Su. 2000. Mekk3 is essential for early embryonic cardiovascular development. Nat. Genet. 24: 309-313.
11. Johnson, G. L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912. (Pubitemid 35425238)
12. Su, B. 2005. Linking stress to immunity? Nat. Immunol. 6: 541-542.
13. Deng, Y., J. Yang, M. McCarty, and B. Su. 2007. MEKK3 is required for endothelium function but is not essential for tumor growth and angiogenesis. Am. J. Physiol. Cell Physiol. 293: C1404-C1411.
14. Cheng, J., L. Yu, D. Zhang, Q. Huang, D. M. Spencer, and B. Su. 2005. Dimerization through the catalytic domain is essential for MEKK2 activation. J. Biol. Chem. 280: 13477-13482.
15. Zhang, D., V. Facchinetti, X. Wang, Q. Huang, J. Qin, and B. Su. 2006. Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways. EMBO J. 25: 97-107. (Pubitemid 43077299)
16. Huang, Q., J. Yang, Y. Lin, C. Walker, J. Cheng, Z. G. Liu, and B. Su. 2004. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat. Immunol. 5: 98-103.
17. Blonska, M., P. B. Shambharkar, M. Kobayashi, D. Zhang, H. Sakurai, B. Su, and X. Lin. 2005. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation. J. Biol. Chem. 280: 43056-43063.
18. Yang, J., Y. Lin, Z. Guo, J. Cheng, J. Huang, L. Deng, W. Liao, Z. Chen, Z. Liu, and B. Su. 2001. The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat. Immunol. 2: 620-624.
19. Qin, J., J. Yao, G. Cui, H. Xiao, T. W. Kim, J. Fraczek, P. Wightman, S. Sato, S. Akira, A. Puel, et al. 2006. TLR8-mediated NF-kappaB and JNK activation are TAK1-independent and MEKK3-dependent. J. Biol. Chem. 281: 21013-21021.
20. Blonska, M., P. B. Shambharkar, M. Kobayashi, D. Zhang, H. Sakurai, B. Su, and X. Lin. 2005. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappa B activation. J. Biol. Chem. 280: 43056-43063.
21. Yamazaki, K., J. Gohda, A. Kanayama, Y. Miyamoto, H. Sakurai, M. Yamamoto, S. Akira, H. Hayashi, B. Su, and J. Inoue. 2009. Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. Sci. Signal. 2: ra66.
22. Di, Y., S. Li, L. Wang, Y. Zhang, and M. E. Dorf. 2008. Homeostatic interactions between MEKK3 and TAK1 involved in NF-kappaB signaling. Cell. Signal. 20: 705-713.
23. Wang, X., X. Chang, V. Facchinetti, Y. Zhuang, and B. Su. 2009. MEKK3 is essential for lymphopenia-induced T cell proliferation and survival. J. Immunol. 182: 3597-3608.
24. Shinohara, H., S. Yamasaki, S. Maeda, T. Saito, and T. Kurosaki. 2009. Regulation of NF-kappaB-dependent T cell activation and development by MEKK3. Int. Immunol. 21: 393-401.
25. Pope, C., S. K. Kim, A. Marzo, D. Masopust, K. Williams, J. Jiang, H. Shen, and L. Lefrançois. 2001. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J. Immunol. 166: 3402-3409. (Pubitemid 33117342)
26. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
27. Shedlock, D. J., J. K. Whitmire, J. Tan, A. S. MacDonald, R. Ahmed, and H. Shen. 2003. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J. Immunol. 170: 2053-2063. (Pubitemid 36197427)
28. Li, B., H. Yu, W. Zheng, R. Voll, S. Na, A. W. Roberts, D. A. Williams, R. J. Davis, S. Ghosh, and R. A. Flavell. 2000. Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science 288: 2219-2222.
29. Lu, B., H. Yu, C. Chow, B. Li, W. Zheng, R. J. Davis, and R. A. Flavell. 2001. GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity 14: 583-590.
30. Uhlik, M. T., A. N. Abell, N. L. Johnson, W. Sun, B. D. Cuevas, K. E. Lobel-Rice, E. A. Horne, M. L. Dell'Acqua, and G. L. Johnson. 2003. Rac-MEKK3- MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell Biol. 5: 1104-1110.
31. Akbar, H., J. Cancelas, D. A. Williams, J. Zheng, and Y. Zheng. 2006. Rational design and applications of a Rac GTPase-specific small molecule inhibitor. Methods Enzymol. 406: 554-565. (Pubitemid 43207468)
32. Nassar, N., J. Cancelas, J. Zheng, D. A. Williams, and Y. Zheng. 2006. Structure-function based design of small molecule inhibitors targeting Rho family GTPases. Curr. Top. Med. Chem. 6: 1109-1116.
33. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.
34. Edelson, B. T., and E. R. Unanue. 2000. Immunity to Listeria infection. Curr. Opin. Immunol. 12: 425-431.
35. Murphy, K. M., and S. L. Reiner. 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2: 933-944.
36. Chi, H., B. Lu, M. Takekawa, R. J. Davis, and R. A. Flavell. 2004. GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells. EMBO J. 23: 1576-1586.
37. Deacon, K., and J. L. Blank. 1997. Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo. J. Biol. Chem. 272: 14489-14496.
38. Sahoo, T., E. W. Johnson, J. W. Thomas, P. M. Kuehl, T. L. Jones, C. G. Dokken, J. W. Touchman, C. J. Gallione, S. Q. Lee-Lin, B. Kosofsky, et al. 1999. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum. Mol. Genet. 8: 2325-2333.
39. Rubinson, D. A., C. P. Dillon, A. V. Kwiatkowski, C. Sievers, L. Yang, J. Kopinja, D. L. Rooney, M. Zhang, M. M. Ihrig, M. T. McManus, et al. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33: 401-406.
40. Morton, A. M., B. McManus, P. Garside, A. M. Mowat, and M. M. Harnett. 2007. Inverse Rap1 and phospho-ERK expression discriminate the maintenance phase of tolerance and priming of antigen-specific CD4+ T cells in vitro and in vivo. J. Immunol. 179: 8026-8034.
41. Hilder, T. L., M. H. Malone, S. Bencharit, J. Colicelli, T. A. Haystead, G. L. Johnson, and C. C. Wu. 2007. Proteomic identification of the cerebral cavernous malformation signaling complex. J. Proteome Res. 6: 4343-4355.
42. Kang, Z. B., Y. Ge, Z. Chen, J. Cluette-Brown, M. Laposata, A. Leaf, and J. X. Kang. 2001. Adenoviral gene transfer of Caenorhabditis elegans n - 3 fatty acid desaturase optimizes fatty acid composition in mammalian cells. Proc. Natl. Acad. Sci. USA 98: 4050-4054.
43. Coso, O. A., M. Chiariello, J. C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81: 1137-1146.
44. Teramoto, H., O. A. Coso, H. Miyata, T. Igishi, T. Miki, and J. S. Gutkind. 1996. Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family. J. Biol. Chem. 271: 27225-27228.
45. Guo, F., J. A. Cancelas, D. Hildeman, D. A. Williams, and Y. Zheng. 2008. Rac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development. Blood 112: 1767-1775.